Yet, information for other prognostic subtypes, such as Ph+ and Ph-like ALL or those with the TEL-AML (ETV6-RUNX1) fusion gene, was not available or lacked sufficient sample size. The gene discussed is RUNX1; the disease is acute lymphoblastic leukemia.